ScreenerHero

ONCO Oncopeptides AB (publ)

STO · SE · Healthcare · Biotechnology · oncopeptides.com
2.052SEK-0.39%Mkt Cap: 74.85M $P/E: —

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap74.85M USD
Enterprise Value77.48M USD
Revenue (TTM)9.10M USD
Gross Profit6.57M USD
Net Income (TTM)-23.87M USD
Revenue/Share0.34 SEK
Last Price2.052 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees69
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0009414576
Valuation
P/E (Trailing)—
P/E (Forward)-2.97
PEG—
EV/EBITDA-4.18
EV/Revenue8.51
P/S8.44
P/B33.43
EPS (TTM)-0.76
EPS (Forward)-0.71
52W Range
1.26515% of range6.550
52W High6.550 SEK
52W Low1.265 SEK
Profitability
Gross Margin96.55%
Oper. Margin-156.49%
EBITDA Margin-203.45%
Profit Margin-350.94%
ROE423.81%
ROA-184.33%
Growth
Revenue Growth62.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.32M USD
CapEx (TTM)—
FCF Margin-136.24%
FCF Yield-16.57%
Net Debt-2.15M USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity-2.37
Current Ratio3.78
Quick Ratio3.57
Book Value/Sh0.06 SEK
Cash/Share0.40 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.700 SEK
Upside (mean)+31.6%
Target Range2.000 SEK – 3.600 SEK
2.000+31.6% to mean3.600
# Analysts3
Ownership
Shares Out.381.36M
Float379.39M
Insiders3.85%
Institutions14.38%
Technical
SMA 501.819 (+12.8%)
SMA 2002.032 (+1.0%)
Beta-1.31
S&P 52W Chg14.58%
Avg Vol (30d)4.57M
Avg Vol (10d)5.65M
Technical Indicators
RSI (14)51.3
MACD0.1004
MACD Signal0.1258
MACD Hist.-0.0254
BB Upper2.672 SEK
BB Middle2.036 SEK
BB Lower1.401 SEK
BB Width62.40%
ATR (14)0.1528 SEK
Vol Ratio (20d)0.50x